DongKook Pharmaceutical Co. Ltd (086450) — Cash Flow Quality Index
DongKook Pharmaceutical Co. Ltd (086450) has a Cash Flow Quality Index of 1.70x as of December 2025. Operating cash flow of ₩23.53 Billion exceeds net income of ₩13.85 Billion, indicating high earnings quality where cash backs reported profits. Explore 086450 long-term investment intensity to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
DongKook Pharmaceutical Co. Ltd Cash Flow Quality Index (2013–2025)
Historical Cash Flow Quality Index for DongKook Pharmaceutical Co. Ltd across 13 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 086450 tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for DongKook Pharmaceutical Co. Ltd (2013–2025)
Year-by-year earnings quality comparison for DongKook Pharmaceutical Co. Ltd. For live market cap and the full company financial profile, see DongKook Pharmaceutical Co. Ltd (086450) total market value.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.04x | ₩68.76 Billion | ₩66.02 Billion | ▼ -16.2% |
| 2024 | 1.24x | ₩76.09 Billion | ₩61.22 Billion | ▲ +40.3% |
| 2023 | 0.89x | ₩41.79 Billion | ₩47.18 Billion | ▲ +14.5% |
| 2022 | 0.77x | ₩40.91 Billion | ₩52.90 Billion | ▼ -12.8% |
| 2021 | 0.89x | ₩44.65 Billion | ₩50.35 Billion | ▼ -14.0% |
| 2020 | 1.03x | ₩59.11 Billion | ₩57.29 Billion | ▼ -16.4% |
| 2019 | 1.23x | ₩69.48 Billion | ₩56.31 Billion | ▲ +74.4% |
| 2018 | 0.71x | ₩33.21 Billion | ₩46.95 Billion | ▼ -2.3% |
| 2017 | 0.72x | ₩28.66 Billion | ₩39.60 Billion | ▼ -25.3% |
| 2016 | 0.97x | ₩39.41 Billion | ₩40.69 Billion | ▼ -2.8% |
| 2015 | 1.00x | ₩27.14 Billion | ₩27.23 Billion | ▼ -7.5% |
| 2014 | 1.08x | ₩22.74 Billion | ₩21.10 Billion | ▼ -9.0% |
| 2013 | 1.18x | ₩19.86 Billion | ₩16.76 Billion | — |